Accelerated Partial Breast Irradiation

Accelerated Partial Breast Irradiation (APBI) represents a change in the way early-stage breast cancer is managed in many patients. Conceived, developed and implemented first at Beaumont, this technology replaces the standard six to seven weeks of radiation therapy with a five-day treatment to a smaller, more targeted area in the breast.

With more than a decade of experience treating patients with this technique, Beaumont is now the principal institution in an NCI-sponsored clinical trial comparing APBI to standard treatment in 3,000 patients.

Beaumont is also one of a handful of centers that offers its patients all three forms of APBI:

  • the mammosite breast brachytherapy catheter
  • catheter-based interstitial brachytherapy
  • 3-D conformed external beam irradiation

It is anticipated that the use of this technique will increase in the future since it potentially offers patients similar outcomes with significantly reduced treatment times.